iXCells Biotechnologies

For the first time in iXCells history, we’re offering a special year-end discount on select services. If you’re preparing new studies or expanding your pipeline, now is the perfect opportunity to maximize value and advance your research with iXCells as your scientific partner. Submit your project details and finalize contracts by December 31 to access this limited offer. https://bit.ly/3MaW8gv We’re excited to support your breakthroughs in 2026 #iPSCore #crispr #geneediting #drugdiscovery

If you’re planning preclinical work for 2026, now is the time to explore service support from iXCells. To help research teams move into the new year with momentum, we’re offering limited-time pricing on our end-to-end CRO services, including iPSC generation, genome editing, differentiation, and in vitro assay support. To qualify for special pricing, project details must be submitted and contracts finalized by December 31. Here’s what one of our service partners shared about working with our team: “iXCells proved to be an invaluable resource for our pre-clinical programs, and we couldn't be more pleased with the results. Initially drawn to their work through high-profile publications in the ALS field, we were thrilled to collaborate with their team on iPSC reprogramming, neuronal differentiation, and neuron functional assays. Their high-quality data was instrumental in the acceptance of our Nature Communications paper, and we were impressed by their flexibility in accommodating our specific requirements. Not only were their scientists easy to work with, but their reasonable pricing and fast turnover made the entire process seamless. We look forward to continuing our partnership with iXCells and highly recommend their services to anyone in need of top-notch scientific support.” — Yuanjing Liu, PhD Director, CNS Biology, Wave Life Science Secure your special pricing today! Submit your project details: https://bit.ly/3KmjJKD #iPSCore #crispr #geneediting #drugdiscovery #croservices

Strong research requires more than individual capabilities. It requires the scientific expertise to apply them effectively. Across six core services, iXCells supports researchers with specialized knowledge, technical experience, and the flexibility to meet the needs of complex discovery programs: iPSCore An all-in-one iPSC platform for generating predictive, human-relevant models that help drive preclinical drug discovery forward. iPSC Cell Generation Custom reprogramming of somatic cells into fully characterized iPSC lines using non-integrating methods. Genome Editing CRISPR-based editing in iPSCs for isogenic disease models and precision target validation. iPSC Differentiation Reproducible differentiation into neurons, cardiomyocytes, hepatocytes, and other specialized cell types. Custom Cell Isolation Cell isolation tailored to your tissue source, donor criteria, and research application needs. High-Throughput iPSC Scalable, high-volume iPSC screening platforms built for speed, consistency, and drug discovery demands. From model generation and genome engineering to differentiation, scale-up, and custom research support, each service is backed by scientists who understand the biology and the objectives behind the work. Six Core Services. Scientific Expertise Behind Each. Contact an iXCells scientist to learn more. https://lnkd.in/gi83im96/?utm_campaign=Boost_Post_WebsiteVisits_Oct6,2026&utm_source=linkedin&utm_medium=paid&utm_id=1217950746&hsa_acc=515356232&hsa_cam=1217950746&hsa_grp=910079846&hsa_ad=1633381536&hsa_net=linkedin&hsa_ver=3 #iPSC #GenomeEditing #CellBiology #DiseaseModeling #DrugDiscovery #LifeSciences

Every research program begins with a question. What is driving the disease? How does a genetic change affect cell behavior? How might a potential therapy influence the biology? The model used to investigate those questions matters. Researchers around the world can work with our scientists to develop human-relevant cell models around specific study objectives—from patient-derived iPSCs and genome-edited lines to differentiated cell types and advanced 3D models. The goal is not simply to create a model that performs consistently. It is to create one that helps researchers study the biology that matters to their program. Start with the question. Build the model around it. Contact an iXCells scientist to discuss your next research program. https://lnkd.in/gi83im96/?utm_campaign=Boost_Post_WebsiteVisits_Oct6,2026&utm_source=linkedin&utm_medium=paid&utm_id=1217950746&hsa_acc=515356232&hsa_cam=1217950746&hsa_grp=910079846&hsa_ad=1633244966&hsa_net=linkedin&hsa_ver=3

The right research model starts with the right biology. Scientists at iXCells develop human cell-based models designed around the specific questions researchers need to answer—from disease mechanisms and genetic changes to cellular behavior and therapeutic response. Our capabilities include patient-derived iPSCs, genome-edited cell lines, differentiated cell types, primary cells, and advanced 3D systems. We work with research teams to develop and characterize models that are relevant to the biology being studied and ready to support downstream discovery programs. Because no model can reproduce every aspect of human biology, selecting and developing the right system matters. The right model captures the biology that matters. Contact an iXCells scientist to discuss the right model for your next research project. https://bit.ly/4yonHpJ

Scaling iPSC production for large-scale research starts with a simple question: Can your current workflow support hundreds—or even thousands—of iPSC lines? As research programs grow, generating large numbers of patient-derived iPSC lines can quickly become a bottleneck. iXCells' high-throughput iPSC production platform is designed to help researchers overcome that challenge, providing the scale, consistency, and quality needed for large cohort studies, disease modeling, and drug discovery. From donor sample collection and reprogramming to characterization and delivery, our team helps streamline the production of large iPSC cohorts so researchers can focus on advancing their science. When your research demands more than a handful of cell lines, we're ready to help. https://bit.ly/4ekPoXy #biopharma #drugdiscovery #ipsc #croservices